Role of Bisphosphonates in Prostate Cancer

By Saad F.   Schulman C.C.  

European Urology, Vol. 45, Iss. 1, 2004-01 ,pp. : 26-34

Elsevier

Access to resources Recommend Favorite

The role of the insulin-like growth factor receptor, the insulin receptor substrate and PTEN in human prostate cancer progression

By Hellawell G.   Turner G.   Davies D.   Brewster S.   Macaulay V.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 33-33

Elsevier

Access to resources Recommend Favorite

Osteoprotegerin and rank ligand expression in prostate cancer

By Brown J.M.   Corey E.   Lee Z.D.   True L.D.   Yun T.J.   Tondravi M.   Vessella R.L.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 611-616

Elsevier

Access to resources Recommend Favorite

Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis

By Shariat S.F.   Andrews B.   Kattan M.W.   Kim J.   Wheeler T.M.   Slawin K.M.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 1008-1015

Elsevier

Access to resources Recommend Favorite

Role of angiopoietins (ANG1 and ANG2) and their receptor TIE-2 in the vascularisation of human prostate cancer

By Hammerer P.   Wurmbach J.   Sevinc S.   Huland H.   Graefen M.   Ergun S.  

European Urology Supplements, Vol. 1, Iss. 1, 2002-01 ,pp. : 53-53

Elsevier

Access to resources Recommend Favorite